financetom
Business
financetom
/
Business
/
Burke & Herbert Financial Services Q1 Adjusted Earnings, Revenue Drop
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Burke & Herbert Financial Services Q1 Adjusted Earnings, Revenue Drop
Apr 26, 2024 10:53 AM

01:37 PM EDT, 04/26/2024 (MT Newswires) -- Burke & Herbert Financial Services (BHRB) reported Q1 adjusted earnings Friday of $0.76 per diluted share, down from $1.02 a year earlier.

Revenue for the quarter ended March 31 was $26.4 million, down from $29.0 million a year earlier.

Capital IQ estimates weren't available for comparison.

The company's shares were up 1.4% in recent trading.

Price: 55.00, Change: +0.74, Percent Change: +1.36

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Mustang Energy Completes 1st Phase of Exploration at Surprise Creek Project, Provides Update on Ford Lake Project Deal
Mustang Energy Completes 1st Phase of Exploration at Surprise Creek Project, Provides Update on Ford Lake Project Deal
Aug 25, 2025
06:18 AM EDT, 08/25/2025 (MT Newswires) -- Mustang Energy ( MECPF ) late on Friday said it has completed the first phase of field exploration activities on the Surprise Creek uranium-copper project in Saskatchewan and also agreed to acquire an 80% stake in the project. The field program at Surprise Creek included surface prospecting activities and detailed rock sampling to...
BeOne Medicines Sells Imdelltra Royalties to Royalty Pharma for Up to $950 Million
BeOne Medicines Sells Imdelltra Royalties to Royalty Pharma for Up to $950 Million
Aug 25, 2025
06:22 AM EDT, 08/25/2025 (MT Newswires) -- BeOne Medicines ( ONC ) said Monday it has agreed to sell its royalty rights, excluding China, on Amgen's lung cancer drug, Imdelltra, to Royalty Pharma ( RPRX ) for up to $950 million. Under the deal, the company said it would receive an upfront payment of $885 million, with an option to...
Coca-Cola explores sale of Costa Coffee, source says
Coca-Cola explores sale of Costa Coffee, source says
Aug 25, 2025
(Reuters) -U.S. soft drinks company Coca-Cola is working with investment bank Lazard to review options, including a potential sale, of British coffee chain Costa, a source familiar with the matter told Reuters on Sunday. Coca-Cola did not immediately respond to a request for a comment outside regular business hours. Costa, and Lazard did not immediately respond to requests for comment....
Royalty Pharma to buy royalty interest in Amgen's lung cancer drug for up to $950 million
Royalty Pharma to buy royalty interest in Amgen's lung cancer drug for up to $950 million
Aug 25, 2025
Aug 25 (Reuters) - Royalty Pharma ( RPRX ) said on Monday it has signed a deal with BeOne Medicines to acquire a royalty interest in Amgen's ( AMGN ) drug for small cell lung cancer for up to $950 million. The deal gives Royalty Pharma ( RPRX ) access to roughly 7% of global net sales of the therapy,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved